Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Maintenance erlotinib in advanced nonsmall cell lung cancer: cost-effectiveness in EGFR wild-type across Europe

Total article views   Abstract views HTML views PDF downloads Totals
10,623 Dovepress* 8,801 610+ 1,787 9,411
PubMed Central* 2 1,210 615 1,212
Totals 8,803 1,820 2,402 10,623
*Since 14 September 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed Central and Google Scholar